Industry: Chemical & Material
Published Date: 2026-07-14
Pages: 141 Pages
Report ld: 6923987
Request Sample
Customized Report
The global market for N-hydroxyoctanamid was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
The North American market for N-hydroxyoctanamid was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for N-hydroxyoctanamid was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for N-hydroxyoctanamid was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the N-hydroxyoctanamid market include Inolex, Simagchem Corporation, Hangzhou Lingeba Technology, TCI, Wuhan 3B Scientific Corporation, HBCChem, Inc, Beijing Yunbang Biosciences, BePharm Ltd, Yolne reagent, Aladdin, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for N-hydroxyoctanamid, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The N-hydroxyoctanamid market size, estimations, and forecasts are presented in terms of sales volume (K MT) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding N-hydroxyoctanamid.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the N-hydroxyoctanamid manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents N-hydroxyoctanamid sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents N-hydroxyoctanamid sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 N-hydroxyoctanamid Product Introduction
1.2 Global N-hydroxyoctanamid Market Size Forecast
1.2.1 Global N-hydroxyoctanamid Sales Value (2021–2032)
1.2.2 Global N-hydroxyoctanamid Sales Volume (2021–2032)
1.2.3 Global N-hydroxyoctanamid Sales Price (2021–2032)
1.3 N-hydroxyoctanamid Market Trends & Drivers
1.3.1 N-hydroxyoctanamid Industry Trends
1.3.2 N-hydroxyoctanamid Market Drivers & Opportunities
1.3.3 N-hydroxyoctanamid Market Challenges
1.3.4 N-hydroxyoctanamid Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global N-hydroxyoctanamid Players Revenue Ranking (2025)
2.2 Global N-hydroxyoctanamid Revenue by Company (2021–2026)
2.3 Global N-hydroxyoctanamid Sales Volume Ranking of Players (2025)
2.4 Global N-hydroxyoctanamid Sales Volume by Company (2021–2026)
2.5 Global N-hydroxyoctanamid Average Price by Company (2021–2026)
2.6 Key Manufacturers N-hydroxyoctanamid Manufacturing Base and Headquarters
2.7 Key Manufacturers N-hydroxyoctanamid Product Offerings
2.8 Key Manufacturers Start of Mass Production of N-hydroxyoctanamid
2.9 N-hydroxyoctanamid Market Competitive Analysis
2.9.1 N-hydroxyoctanamid Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by N-hydroxyoctanamid Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on N-hydroxyoctanamid revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation N-hydroxyoctanamid Market Classification
3.1 Introduction by Type
3.1.1 Liquid
3.1.2 Powder
3.1.3 Global N-hydroxyoctanamid Sales Value by Type
3.1.3.1 Global N-hydroxyoctanamid Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global N-hydroxyoctanamid Sales Value, by Type (2021–2032)
3.1.3.3 Global N-hydroxyoctanamid Sales Value, by Type (%), 2021–2032
3.1.4 Global N-hydroxyoctanamid Sales Volume by Type
3.1.4.1 Global N-hydroxyoctanamid Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global N-hydroxyoctanamid Sales Volume, by Type (2021–2032)
3.1.4.3 Global N-hydroxyoctanamid Sales Volume, by Type (%), 2021–2032
3.1.5 Global N-hydroxyoctanamid Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cosmetics additives
4.1.2 Pharmaceutical intermediates
4.1.3 Other
4.2 Global N-hydroxyoctanamid Sales Value by Application
4.2.1 Global N-hydroxyoctanamid Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global N-hydroxyoctanamid Sales Value, by Application (2021–2032)
4.2.3 Global N-hydroxyoctanamid Sales Value, by Application (%), 2021–2032
4.3 Global N-hydroxyoctanamid Sales Volume by Application
4.3.1 Global N-hydroxyoctanamid Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global N-hydroxyoctanamid Sales Volume, by Application (2021–2032)
4.3.3 Global N-hydroxyoctanamid Sales Volume, by Application (%), 2021–2032
4.4 Global N-hydroxyoctanamid Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global N-hydroxyoctanamid Sales Value by Region
5.1.1 Global N-hydroxyoctanamid Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global N-hydroxyoctanamid Sales Value by Region (2021–2026)
5.1.3 Global N-hydroxyoctanamid Sales Value by Region (2027–2032)
5.1.4 Global N-hydroxyoctanamid Sales Value by Region (%), 2021–2032
5.2 Global N-hydroxyoctanamid Sales Volume by Region
5.2.1 Global N-hydroxyoctanamid Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global N-hydroxyoctanamid Sales Volume by Region (2021–2026)
5.2.3 Global N-hydroxyoctanamid Sales Volume by Region (2027–2032)
5.2.4 Global N-hydroxyoctanamid Sales Volume by Region (%), 2021–2032
5.3 Global N-hydroxyoctanamid Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America N-hydroxyoctanamid Sales Value, 2021–2032
5.4.2 North America N-hydroxyoctanamid Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe N-hydroxyoctanamid Sales Value, 2021–2032
5.5.2 Europe N-hydroxyoctanamid Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific N-hydroxyoctanamid Sales Value, 2021–2032
5.6.2 Asia Pacific N-hydroxyoctanamid Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America N-hydroxyoctanamid Sales Value, 2021–2032
5.7.2 South America N-hydroxyoctanamid Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa N-hydroxyoctanamid Sales Value, 2021–2032
5.8.2 Middle East & Africa N-hydroxyoctanamid Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions N-hydroxyoctanamid Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions N-hydroxyoctanamid Sales Value and Sales Volume
6.2.1 Key Countries/Regions N-hydroxyoctanamid Sales Value, 2021–2032
6.2.2 Key Countries/Regions N-hydroxyoctanamid Sales Volume, 2021–2032
6.3 United States
6.3.1 United States N-hydroxyoctanamid Sales Value, 2021–2032
6.3.2 United States N-hydroxyoctanamid Sales Value by Type (%), 2025 vs 2032
6.3.3 United States N-hydroxyoctanamid Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe N-hydroxyoctanamid Sales Value, 2021–2032
6.4.2 Europe N-hydroxyoctanamid Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe N-hydroxyoctanamid Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China N-hydroxyoctanamid Sales Value, 2021–2032
6.5.2 China N-hydroxyoctanamid Sales Value by Type (%), 2025 vs 2032
6.5.3 China N-hydroxyoctanamid Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan N-hydroxyoctanamid Sales Value, 2021–2032
6.6.2 Japan N-hydroxyoctanamid Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan N-hydroxyoctanamid Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea N-hydroxyoctanamid Sales Value, 2021–2032
6.7.2 South Korea N-hydroxyoctanamid Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea N-hydroxyoctanamid Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia N-hydroxyoctanamid Sales Value, 2021–2032
6.8.2 Southeast Asia N-hydroxyoctanamid Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia N-hydroxyoctanamid Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India N-hydroxyoctanamid Sales Value, 2021–2032
6.9.2 India N-hydroxyoctanamid Sales Value by Type (%), 2025 vs 2032
6.9.3 India N-hydroxyoctanamid Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Inolex
7.1.1 Inolex Company Information
7.1.2 Inolex Introduction and Business Overview
7.1.3 Inolex N-hydroxyoctanamid Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Inolex N-hydroxyoctanamid Product Offerings
7.1.5 Inolex Recent Developments
7.2 Simagchem Corporation
7.2.1 Simagchem Corporation Company Information
7.2.2 Simagchem Corporation Introduction and Business Overview
7.2.3 Simagchem Corporation N-hydroxyoctanamid Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Simagchem Corporation N-hydroxyoctanamid Product Offerings
7.2.5 Simagchem Corporation Recent Developments
7.3 Hangzhou Lingeba Technology
7.3.1 Hangzhou Lingeba Technology Company Information
7.3.2 Hangzhou Lingeba Technology Introduction and Business Overview
7.3.3 Hangzhou Lingeba Technology N-hydroxyoctanamid Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Hangzhou Lingeba Technology N-hydroxyoctanamid Product Offerings
7.3.5 Hangzhou Lingeba Technology Recent Developments
7.4 TCI
7.4.1 TCI Company Information
7.4.2 TCI Introduction and Business Overview
7.4.3 TCI N-hydroxyoctanamid Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 TCI N-hydroxyoctanamid Product Offerings
7.4.5 TCI Recent Developments
7.5 Wuhan 3B Scientific Corporation
7.5.1 Wuhan 3B Scientific Corporation Company Information
7.5.2 Wuhan 3B Scientific Corporation Introduction and Business Overview
7.5.3 Wuhan 3B Scientific Corporation N-hydroxyoctanamid Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Wuhan 3B Scientific Corporation N-hydroxyoctanamid Product Offerings
7.5.5 Wuhan 3B Scientific Corporation Recent Developments
7.6 HBCChem, Inc
7.6.1 HBCChem, Inc Company Information
7.6.2 HBCChem, Inc Introduction and Business Overview
7.6.3 HBCChem, Inc N-hydroxyoctanamid Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 HBCChem, Inc N-hydroxyoctanamid Product Offerings
7.6.5 HBCChem, Inc Recent Developments
7.7 Beijing Yunbang Biosciences
7.7.1 Beijing Yunbang Biosciences Company Information
7.7.2 Beijing Yunbang Biosciences Introduction and Business Overview
7.7.3 Beijing Yunbang Biosciences N-hydroxyoctanamid Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Beijing Yunbang Biosciences N-hydroxyoctanamid Product Offerings
7.7.5 Beijing Yunbang Biosciences Recent Developments
7.8 BePharm Ltd
7.8.1 BePharm Ltd Company Information
7.8.2 BePharm Ltd Introduction and Business Overview
7.8.3 BePharm Ltd N-hydroxyoctanamid Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 BePharm Ltd N-hydroxyoctanamid Product Offerings
7.8.5 BePharm Ltd Recent Developments
7.9 Yolne reagent
7.9.1 Yolne reagent Company Information
7.9.2 Yolne reagent Introduction and Business Overview
7.9.3 Yolne reagent N-hydroxyoctanamid Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Yolne reagent N-hydroxyoctanamid Product Offerings
7.9.5 Yolne reagent Recent Developments
7.10 Aladdin
7.10.1 Aladdin Company Information
7.10.2 Aladdin Introduction and Business Overview
7.10.3 Aladdin N-hydroxyoctanamid Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Aladdin N-hydroxyoctanamid Product Offerings
7.10.5 Aladdin Recent Developments
7.11 Hunan Hecheng
7.11.1 Hunan Hecheng Company Information
7.11.2 Hunan Hecheng Introduction and Business Overview
7.11.3 Hunan Hecheng N-hydroxyoctanamid Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Hunan Hecheng N-hydroxyoctanamid Product Offerings
7.11.5 Hunan Hecheng Recent Developments
8 Industry Chain Analysis
8.1 N-hydroxyoctanamid Industrial Chain
8.2 N-hydroxyoctanamid Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 N-hydroxyoctanamid Sales Model
8.5.2 Sales Channels
8.5.3 N-hydroxyoctanamid Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global N-hydroxyoctanamid market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 137
USD 2900.00
(Single User License)
The global N-hydroxyoctanamid market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 153
USD 4900.00
(Single User License)
The global N-hydroxyoctanamid market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 93
USD 4250.00
(Single User License)
The global market for N-hydroxyoctanamid was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 112
USD 3950.00
(Single User License)
The global market for N-hydroxyoctanamid was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-24
Pages: 104
USD 2900.00
(Single User License)
The global N-hydroxyoctanamid market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-12
Pages: 109
USD 4900.00
(Single User License)
The global market for N-hydroxyoctanamid was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-24
Pages: 121
USD 3950.00
(Single User License)
The global N-hydroxyoctanamid market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-16
Pages: 104
USD 2900.00
(Single User License)
The global N-hydroxyoctanamid market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 137
The global N-hydroxyoctanamid market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 153
The global N-hydroxyoctanamid market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 93
The global market for N-hydroxyoctanamid was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 112
The global market for N-hydroxyoctanamid was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-24
Pages: 104
The global N-hydroxyoctanamid market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-12
Pages: 109
The global market for N-hydroxyoctanamid was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-24
Pages: 121
The global N-hydroxyoctanamid market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-16
Pages: 104
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now